Enjoy complimentary customisation on priority with our Enterprise License!
The Global Female Contraceptive Market is forecast to increase by USD 5.14 billion at a CAGR of 5.32% between 2022 and 2027. The market is influenced by diverse drivers. The adoption of innovative marketing strategies amplifies awareness and accessibility of contraceptive options for women worldwide. Evolving consumer perspectives towards reproductive health and family planning further fuel market growth. Additionally, the availability of various contraception methods offers women a broader range of choices, contributing to the expansion of the global market for female contraceptives. This market research report also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The market share growth by the offline segment will be significant during the forecast period. This segment includes adult stores and vending machines. The segment will grow at a moderate rate due to the low presence of these stores near residential complexes and localities. However, with the growing real estate sector, these establishments are setting up bases close to family neighborhoods to sustain healthy revenue. This segment affects the sales of convenience stores, merchandisers, and drugstores to an extent.
Get a glance at the market contribution of various segments Request a PDF Sample
The offline segment showed a gradual increase in market share with USD 10.03 billion in 2017 and continued to grow by 2021. Vending machines also contribute significant revenue to the segment and the global market. Countries such as the US, the UK, France, Germany, China, and Japan have a large number of branded condom vending machines. Also, in many countries, governments, health organizations, and NGOs are installing vending machines that provide condoms at a low cost, which is expected to drive the growth of the segment during the forecast period.
This segment is expected to grow at a rapid pace during the forecast period. The sales of female contraceptives through online channels have been boosted by changes in shopping preferences. Presently, the majority of customers are relying on online research through websites, blogs, and social media to make purchase decisions. This trend is being driven by the widespread penetration and geographical reach of e-commerce giants like Amazon, Alibaba, and JD. The availability of a robust infrastructure for e-commerce services has also led to a surge in demand for the online distribution channel. The growth of this sector is expected to be fueled by increasing internet penetration and the growing usage of smartphones in the coming forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is projected to contribute 38% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market in North America is growing due to high product penetration and availability. The availability of advanced female contraceptive products such as IUDs has driven the growth of the market in the region. As these devices are considered effective in preventing pregnancies and are cost-effective as they are generally used for longer periods of time, their demand is increasing in the region.
In the market, addressing Sexually transmitted infections (STDs) and unintended pregnancies aligns with Sustainable Development Goals, aiming to reduce maternal fatalities and promote reproductive health. Evra and sub-dermal contraceptive implants offer options for women with unmet contraceptive needs, targeting reproductive-age women through family planning initiatives. Programs aimed at reducing unwanted pregnancies contribute to achieving healthcare goals while raising user awareness levels. Collaborative efforts by organizations like The Lancet Global Health and Every Woman Every Child support Millennium Development Goals and 2030 Sustainable Development Goals (SDGs), engaging the private sector, pharmacy/drug shops, private clinics, NGOs or faith-based organizations, and the public sector in low- and middle-income countries (LMIC). Youth education promotes safe sex practices, furthering the objectives of the global market. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Addressing the healthcare needs of female vitiligo patients is crucial, as this skin condition can significantly impact quality of life. Similarly, osteoporosis poses significant health risks, especially for postmenopausal women, highlighting the importance of early detection and treatment. In the realm of contraceptive options, Patient enrolment milestone signifies progress in research and development. Beyond traditional methods, Other methods of contraceptives like the topical contraceptives offer alternative choices, while diaphragms and caps provide non-hormonal options for women seeking contraception. Medications and surgery play vital roles in treating various health conditions, including osteoporosis and vitiligo. Additionally, education about sexually transmitted infections (STIs) is essential for maintaining sexual health, particularly among the young population, who may lack adequate knowledge of sexual health practices. By fostering understanding and awareness of sexual health issues, healthcare providers can empower individuals to make informed decisions about contraception and STI prevention. Through comprehensive care and education, we can support the well-being of female vitiligo patients, address osteoporosis risks, and promote sexual health among the young population.
The global growth of the market is driven by the increasing adoption of innovative marketing strategies. Companies are investing heavily in advertising and marketing efforts to address unmet contraceptive needs among reproductive-age women, aiming to reduce unintended pregnancies and maternal fatalities. Leading contraceptive brands are allocating substantial resources to marketing activities, collaborating with various stakeholders such as NGOs, private clinics, and public sector initiatives like Every Woman Every Child.
These efforts include print advertisements, events, and short-term video advertisements, targeting women from diverse demographics and promoting contraceptive methods like sub-dermal contraceptive implants and birth control pills. By raising awareness and encouraging discussions about safe sex and family planning, these marketing initiatives contribute to the market's growth and help address the unmet demand for contraception.
The increasing popularity of female condoms will fuel the global market growth. The market has been witnessing the rising popularity of female condoms in the past two years. In developed countries, the adoption of female condoms is increasing, which is creating a demand for such products. In the US, the government is distributing a large number of female condoms through beauty salons, convenience stores, and clinics under its DC program to curb the rising rates of HIV infections in the country. Also, trained officials communicate with women to know about their sexual health, which helps achieve higher acceptance rates for female condoms.
Moreover, the second-generation female condoms manufactured by FH2 (a brand of Veru) have reduced the cost of female condoms and made their pricing equivalent to that of male condoms. Female condoms are critically important, especially for high-risk sex workers who may face condom refusal. Also, they are an ideal alternative to contraceptive pills for women who prefer not to use hormonal methods to prevent pregnancy. Therefore, these factors are increasing the popularity of female condoms globally.
Non-uniformity in sex education in developed countries is a major challenge to the global market growth. While developed countries such as the US consider themselves sexually liberated countries, non-uniformity in imparting sex education is affecting awareness of sex among teenagers, which is reducing the demand for female contraceptives. If teenagers are not educated properly about the various aspects of sex, the use of female contraceptives will be limited among them.
In the US, in several states, there is a focus on abstinence-only sex education, which is a form of sex education that promotes and teaches students not to have sex outside marriage or premarital sex. Furthermore, such education excludes the teaching of birth control measures and safe sex. This has increased teenage pregnancy rates. Therefore, unless proper and scientifically accurate sex education is imparted in schools, the adoption of products such as female condoms will be low, as the youth will not be aware of the availability of such products. This could affect the growth of the global market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Female-Contraceptive Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbvie- The company offers female contraceptives such as Liletta Intrauterine Contraceptive. The company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve its established long-term strategic goals.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:
A qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
The market witnesses a wide array of options catering to various preferences and needs. From traditional methods like intrauterine devices and oral contraceptives to innovative solutions like transdermal patches, Spermicides, and vaginal gels, the market offers diverse choices. Recent developments such as the Dienogest + ethinylestradiol PR and Estelle (drospirenone + estetrol) have marked significant advancements in contraceptive technology. The market continues to grow, with ongoing research and development contributing to the contraceptive pipeline. Despite the Oral contraceptives success and Contemporary contraceptives methods, challenges persist, including the need to address unplanned births and ensure widespread access to effective contraceptive drugs and injections.
The market is witnessing significant advancements and innovations to cater to the diverse needs of the Female population. With options ranging from traditional methods like oral contraceptives and intrauterine devices (IUDs) to newer technologies such as contraceptive injections, vaginal rings, and subcutaneous implants, the market offers a broad spectrum of choices. Oral contraceptives success and hormonal IUDs underscores the effectiveness of these methods in preventing unplanned pregnancies. Moreover, ongoing research into pipeline drugs and late-stage therapies aims to enhance contraceptive options further. However, challenges like adverse reactions and ensuring compliance and adherence remain areas of focus for drug developers and healthcare providers alike, emphasizing the importance of access to contraceptives and awareness of contraceptive methods among women of reproductive age.
The market continues to evolve, addressing the diverse needs and concerns of women worldwide. From traditional methods like oral contraceptives to Contemporary contraceptives options such as barrier contraception and long-term reversible contraception, there's a wide array of choices available. Successes in oral contraceptives have been significant, but concerns like spotting, sore breasts, and headaches highlight the need for ongoing research into novel progestins and extended-cycle COCs. Additionally, access to emergency contraceptive options and sterilization procedures remains crucial in preventing unintended pregnancies. However, challenges such as the prevalence of disorders and adolescent pregnancy persist, emphasizing the importance of public awareness and access to contraception, including generic medications, to promote women's health and reproductive rights.
This market research and growth report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Female-Contraceptive Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.32% |
Market growth 2023-2027 |
USD 5.14 billion |
Market structure |
Fragmented |
YoY growth (%) |
4.2 |
Regional analysis |
North America, Europe, APAC, South America, and the Middle East and Africa |
Performing market contribution |
North America at 38% |
Key countries |
US, Canada, China, Japan, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.